Nomograms for clinically localized prostate cancer. Part I: Radical prostatectomy

Research output: Contribution to journalReview articlepeer-review

Abstract

Many nomograms are currently available for patients' and physicians' use for prediction of pathologic stage based on preoperative parameters, such as prostate-specific antigen (PSA) level, clinical stage (tumor, node, metastasis), and Gleason score from prostate biopsy specimen. Based on the probability of final pathologic stage as well as patient comorbidity and life expectancy, patients and physicians can decide whether definitive local therapy, systemic therapy, or palliative therapy would be most appropriate. Nomograms have also been developed based on preoperative parameters for prediction of biochemical recurrence-free survival outcome following surgery. These nomograms can help patients understand the long-term cancer cure rates after radical prostatectomy.

Original languageEnglish (US)
Pages (from-to)123-130
Number of pages8
JournalSeminars in Urologic Oncology
Volume20
Issue number2
DOIs
StatePublished - Jan 1 2002

Keywords

  • Biochemical
  • Nonograms
  • Pathologic stage
  • Radical prostatectomy
  • Recurrence

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Nomograms for clinically localized prostate cancer. Part I: Radical prostatectomy'. Together they form a unique fingerprint.

Cite this